Microorganisms (Apr 2021)
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
- Maria Deloria Knoll,
- Julia C. Bennett,
- Maria Garcia Quesada,
- Eunice W. Kagucia,
- Meagan E. Peterson,
- Daniel R. Feikin,
- Adam L. Cohen,
- Marissa K. Hetrich,
- Yangyupei Yang,
- Jenna N. Sinkevitch,
- Krow Ampofo,
- Laurie Aukes,
- Sabrina Bacci,
- Godfrey Bigogo,
- Maria-Cristina C. Brandileone,
- Michael G. Bruce,
- Romina Camilli,
- Jesús Castilla,
- Guanhao Chan,
- Grettel Chanto Chacón,
- Pilar Ciruela,
- Heather Cook,
- Mary Corcoran,
- Ron Dagan,
- Kostas Danis,
- Sara de Miguel,
- Philippe De Wals,
- Stefanie Desmet,
- Yvonne Galloway,
- Theano Georgakopoulou,
- Laura L. Hammitt,
- Markus Hilty,
- Pak-Leung Ho,
- Sanjay Jayasinghe,
- James D. Kellner,
- Jackie Kleynhans,
- Mirjam J. Knol,
- Jana Kozakova,
- Karl Gústaf Kristinsson,
- Shamez N. Ladhani,
- Claudia S. Lara,
- Maria Eugenia León,
- Tiia Lepp,
- Grant A. Mackenzie,
- Lucia Mad’arová,
- Allison McGeer,
- Tuya Mungun,
- Jason M. Mwenda,
- J. Pekka Nuorti,
- Néhémie Nzoyikorera,
- Kazunori Oishi,
- Lucia Helena De Oliveira,
- Metka Paragi,
- Tamara Pilishvili,
- Rodrigo Puentes,
- Eric Rafai,
- Samir K. Saha,
- Larisa Savrasova,
- Camelia Savulescu,
- J. Anthony Scott,
- Kevin J. Scott,
- Fatima Serhan,
- Lena Petrova Setchanova,
- Nadja Sinkovec Zorko,
- Anna Skoczyńska,
- Todd D. Swarthout,
- Palle Valentiner-Branth,
- Mark van der Linden,
- Didrik F. Vestrheim,
- Anne von Gottberg,
- Inci Yildirim,
- Kyla Hayford,
- the PSERENADE Team
Affiliations
- Maria Deloria Knoll
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Julia C. Bennett
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Maria Garcia Quesada
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Eunice W. Kagucia
- Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya
- Meagan E. Peterson
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Daniel R. Feikin
- Independent Consultant, 1296 Coppet, Switzerland
- Adam L. Cohen
- World Health Organization, 1202 Geneva, Switzerland
- Marissa K. Hetrich
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Yangyupei Yang
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Jenna N. Sinkevitch
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Krow Ampofo
- Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
- Laurie Aukes
- Vaccine Study Center, Kaiser Permanente, Oakland, CA 94612, USA
- Sabrina Bacci
- European Centre for Disease Prevention and Control, 169 73 Solna, Sweden
- Godfrey Bigogo
- Centre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578-40100, Kisumu, Kenya
- Maria-Cristina C. Brandileone
- National Laboratory for Meningitis and Pneumococcal Infections, Center of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo 01246-902, Brazil
- Michael G. Bruce
- Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA
- Romina Camilli
- Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), 00161 Rome, Italy
- Jesús Castilla
- CIBER Epidemiología y Salud Pública, (CIBERESP), 28029 Madrid, Spain
- Guanhao Chan
- Singapore Ministry of Health, Communicable Diseases Division, Singapore 308442, Singapore
- Grettel Chanto Chacón
- Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Tres Ríos, 30301 Cartago, Costa Rica
- Pilar Ciruela
- CIBER Epidemiología y Salud Pública, (CIBERESP), 28029 Madrid, Spain
- Heather Cook
- Centre for Disease Control, Department of Health and Community Services, Darwin City, NT 8000, Australia
- Mary Corcoran
- Irish Meningitis and Sepsis Reference Laboratory, Children’s Health Ireland at Temple Street, Temple Street, D01 YC76 Dublin 1, Ireland
- Ron Dagan
- The Faculty of Health Sciences, Ben-Gurion University of the Negev, 8410501 Beer-Sheva, Israel
- Kostas Danis
- Santé Publique France, the French National Public Health Agency, FR-94410 Saint Maurice, France
- Sara de Miguel
- Epidemiology Department, Dirección General de Salud Pública, 28009 Madrid, Spain
- Philippe De Wals
- Department of Social and Preventive Medicine, Laval University, Québec, QC G1V 0A6, Canada
- Stefanie Desmet
- Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium
- Yvonne Galloway
- Epidemiology Team, Institute of Environmental Science and Research, Porirua, Wellington 5022, New Zealand
- Theano Georgakopoulou
- National Public Health Organisation, 15123 Athens, Greece
- Laura L. Hammitt
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- Markus Hilty
- Swiss National Reference Centre for invasive Pneumococci, Institute for Infectious Diseases, University of Bern, 3012 Bern, Switzerland
- Pak-Leung Ho
- Department of Microbiology and Carol Yu Centre for Infection, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
- Sanjay Jayasinghe
- National Centre for Immunisation Research and Surveillance and Discipline of Child and Adolescent Health, Children’s Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia
- James D. Kellner
- Department of Pediatrics, University of Calgary, and Alberta Health Services, Calgary, AB T3B 6A8, Canada
- Jackie Kleynhans
- Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Sandringham, Johannesburg 2192, South Africa
- Mirjam J. Knol
- National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands
- Jana Kozakova
- National Institute of Public Health (NIPH), 100 42 Praha, Czech Republic
- Karl Gústaf Kristinsson
- Department of Clinical Microbiology, Landspitali-The National University Hospital, Hringbraut, 101 Reykjavik, Iceland
- Shamez N. Ladhani
- Immunisation and Countermeasures Division, Public Health England, London NW9 5EQ, UK
- Claudia S. Lara
- Servicio de Bacteriología Clínica, Departamento de Bacteriología, INEI-ANLIS “Dr. Carlos G. Malbrán”, Buenos Aires C1282 AFF, Argentina
- Maria Eugenia León
- Laboratorio Central de Salud Pública, Asunción, Paraguay (Central Laboratory of Public Health, Asunción, Paraguay), Asunción, Paraguay
- Tiia Lepp
- Department of Communicable Disease and Control and Health Protection, Public Health Agency of Sweden, 171 82 Solna, Sweden
- Grant A. Mackenzie
- Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK
- Lucia Mad’arová
- National Reference Centre for Pneumococcal and Haemophilus Diseases, Regional Authority of Public Health, 975 56 Banská Bystrica, Slovakia
- Allison McGeer
- Toronto Invasive Bacterial Diseases Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada
- Tuya Mungun
- National Center of Communicable Diseases (NCCD), Ministry of Health, Bayanzurkh District, Ulaanbaatar 13336, Mongolia
- Jason M. Mwenda
- World Health Organization Regional Office for Africa, P.O. Box 06, Brazzaville, Congo
- J. Pekka Nuorti
- Department of Health Security, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland
- Néhémie Nzoyikorera
- Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca 20250, Morocco
- Kazunori Oishi
- Toyama Institute of Health, Imizu, Toyama 939-0363, Japan
- Lucia Helena De Oliveira
- Pan American Health Organization, World Health Organization, Washington, DC 20037, USA
- Metka Paragi
- Centre for Medical Microbiology, National Laboratory of Health, Environment and Food, 2000 Maribor, Slovenia
- Tamara Pilishvili
- National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
- Rodrigo Puentes
- Instituto de Salud Pública de Chile, Santiago 7780050, Santiago Metropolitan, Chile
- Eric Rafai
- Ministry of Health and Medical Services, Suva, Fiji
- Samir K. Saha
- Child Health Research Foundation, Dhaka 1207, Bangladesh
- Larisa Savrasova
- Centre for Disease Prevention and Control of Latvia, 1005 Riga, Latvia
- Camelia Savulescu
- Epidemiology Department, Epiconcept, 75012 Paris, France
- J. Anthony Scott
- Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya
- Kevin J. Scott
- Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, NHS GG&C, Glasgow, G31 2ER, UK
- Fatima Serhan
- World Health Organization, 1202 Geneva, Switzerland
- Lena Petrova Setchanova
- Department of Medical Microbiology, Medical University of Sofia, Faculty of Medicine, 1431 Sofia, Bulgaria
- Nadja Sinkovec Zorko
- Communicable Diseases Centre, National Institute of Public Health, 1000 Ljubljana, Slovenia
- Anna Skoczyńska
- National Reference Centre for Bacterial Meningitis, National Medicines Institute, 00-725 Warsaw, Poland
- Todd D. Swarthout
- Malawi-Liverpool-Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre, Malawi
- Palle Valentiner-Branth
- Infectious Disease Epidemiology and Prevention, Statens Serum Institut, DK-2300 Copenhagen, Denmark
- Mark van der Linden
- National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany
- Didrik F. Vestrheim
- Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway
- Anne von Gottberg
- Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Sandringham, Johannesburg 2192, South Africa
- Inci Yildirim
- Department of Pediatrics, Yale New Haven Children’s Hospital, New Haven, CT 06504, USA
- Kyla Hayford
- Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
- the PSERENADE Team
- DOI
- https://doi.org/10.3390/microorganisms9040742
- Journal volume & issue
-
Vol. 9,
no. 4
p. 742
Abstract
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to estimate the impact of PCV10/13 by age, product, schedule, and syndrome. Here we systematically characterize and summarize the global landscape of routine serotype-specific IPD surveillance in PCV10/13-using countries and describe the subset that are included in PSERENADE. Of 138 countries using PCV10/13 as of 2018, we identified 109 with IPD surveillance systems, 76 of which met PSERENADE data collection eligibility criteria. PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 post-PCV10/13 introduction IPD cases. Pediatric and adult surveillance was represented from all geographic regions but was limited from lower income and high-burden countries. In PSERENADE, 18 sites evaluated PCV10, 42 PCV13, and 17 both; 17 sites used a 3 + 0 schedule, 38 used 2 + 1, 13 used 3 + 1, and 9 used mixed schedules. With such a sizeable and generally representative dataset, PSERENADE will be able to conduct robust analyses to estimate PCV impact and inform policy at national and global levels regarding adult immunization, schedule, and product choice, including for higher valency PCVs on the horizon.
Keywords
- global
- invasive pneumococcal disease
- pneumococcal meningitis
- surveillance
- pneumococcal conjugate vaccines
